Published in J Am Coll Surg on April 01, 2003
Using Bayesian networks to predict survival of liver transplant patients. AMIA Annu Symp Proc (2005) 0.98
Current concepts in transplant surgery: liver transplantation today. Langenbecks Arch Surg (2008) 0.96
Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion. PLoS One (2014) 0.93
Postoperative Insulin-Like Growth Factor 1 Levels Reflect the Graft's Function and Predict Survival after Liver Transplantation. PLoS One (2015) 0.76
Outcomes predictors for hepatic transplantation. J Am Coll Surg (2003) 0.75
Physician predictions of graft survival following liver transplantation. HPB (Oxford) (2007) 0.75
Time spent in hospital after liver transplantation: Effects of primary liver disease and comorbidity. World J Transplant (2016) 0.75
Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med (2006) 4.31
Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol (2004) 3.27
Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl (2002) 2.98
Hepatic ischemia/reperfusion injury--a fresh look. Exp Mol Pathol (2003) 2.81
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell (2011) 2.56
ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology (2013) 2.45
Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transpl (2010) 2.30
Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients. Transplantation (2014) 2.26
Incisional hernia after liver transplantation. J Am Coll Surg (2006) 2.23
Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes (2004) 2.22
Surgical privileging and credentialing: a report of a discussion and study group of the American Surgical Association. J Am Coll Surg (2009) 2.18
Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg (2009) 2.16
Sirolimus-associated pulmonary toxicity. Transplantation (2004) 2.15
Liver transplantation in highest acuity recipients: identifying factors to avoid futility. Ann Surg (2014) 2.13
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. Transplantation (2015) 2.13
Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation (2004) 2.13
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg (2007) 2.12
Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology (2005) 2.04
Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol (2004) 2.01
Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol (2009) 1.97
Survival following liver transplantation from non-heart-beating donors. Ann Surg (2004) 1.96
Center-level factors and racial disparities in living donor kidney transplantation. Am J Kidney Dis (2012) 1.82
Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology (2004) 1.80
MELD fails to measure quality of life in liver transplant candidates. Liver Transpl (2005) 1.79
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg (2004) 1.79
Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients. Transplantation (2012) 1.78
Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg (2005) 1.73
Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl (2003) 1.71
Outcome of liver transplantation in septuagenarians: a single-center experience. Arch Surg (2007) 1.69
Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg (2003) 1.67
Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology (2005) 1.66
Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video). Gastrointest Endosc (2010) 1.65
Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg (2008) 1.65
Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers. Liver Transpl (2013) 1.62
Chronic viral hepatitis and hepatocellular carcinoma. World J Surg (2007) 1.62
Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation. Transplantation (2014) 1.62
Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology (2002) 1.62
The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury. Transplantation (2010) 1.62
Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med (2008) 1.61
Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway. Hepatology (2013) 1.60
Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion. Hepatology (2008) 1.59
Giant cavernous liver hemangiomas: effect of operative approach on outcome. Arch Surg (2004) 1.58
Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg (2007) 1.57
Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury. Hepatology (2008) 1.55
Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg (2012) 1.55
A caspase inhibitor, IDN-6556, ameliorates early hepatic injury in an ex vivo rat model of warm and cold ischemia. Liver Transpl (2007) 1.53
Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant (2005) 1.51
Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg (2011) 1.50
Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J Immunol (2002) 1.50
MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl (2003) 1.49
Outcomes of acute rejection after interferon therapy in liver transplant recipients. Liver Transpl (2004) 1.47
CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology (2008) 1.46
CD154-CD40 T-cell costimulation pathway is required in the mechanism of hepatic ischemia/reperfusion injury, and its blockade facilitates and depends on heme oxygenase-1 mediated cytoprotection. Transplantation (2002) 1.45
Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant (2002) 1.44
Pre-transplant utilization of sorafenib is not associated with increased complications after liver transplantation. Transpl Int (2013) 1.44
Molecular mediators of liver ischemia and reperfusion injury: a brief review. Mol Med (2008) 1.43
Ischaemia-reperfusion injury in liver transplantation--from bench to bedside. Nat Rev Gastroenterol Hepatol (2012) 1.39
RH10 provides superior transgene expression in mice when compared with natural AAV serotypes for neonatal gene therapy. J Gene Med (2010) 1.38
Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology (2004) 1.37
Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival. Am Surg (2003) 1.37
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol (2008) 1.37
Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg (2006) 1.36